Cost-sensitive application infusion device

A - Human Necessities – 61 – M

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61M 5/172 (2006.01) A61M 5/14 (2006.01)

Patent

CA 2366100

A reusable external infusion device infuses a fluid into a individual's body. The infusion device controls the rate that fluid flows from a reservoir inside a housing, through an external tube, and into the individual's body. Essentially, the infused fluid is insulin. However, many other fluids may be administered through infusion such as, HN drugs, drugs to treat pulmonary hypertension, iron chelation drugs, pain medications, anti-cancer treatments, vitamins, hormones, and others.

L'invention concerne un infuseur externe réutilisable servant à infuser un fluide à l'intérieur du corps d'un individu. L'infuseur régule le débit de passage du fluide d'un réservoir logé dans un boîtier au corps de l'individu à travers un tube extérieur. Le fluide infusé est généralement de l'insuline. Toutefois, de nombreux autres fluides peuvent être administrés au moyen de l'infuseur, tels que des médicaments contre le VIH, des médicaments pour traiter l'hypertension pulmonaire, des médicaments de chélation par les métaux, des médicaments contre la douleur, des médicaments de traitement anticancéreux, des vitamines, des hormones, ou autres.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Cost-sensitive application infusion device does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cost-sensitive application infusion device, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cost-sensitive application infusion device will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1733717

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.